ethyl pyruvate has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, Y; Sakamoto, K | 1 |
| Cho, IH; Han, PL; Kim, JB; Kim, SW; Kim, TK; Lee, JK; Lee, KW | 1 |
2 other study(ies) available for ethyl pyruvate and Encephalopathy, Toxic
| Article | Year |
|---|---|
Ethyl pyruvate protects SHSY5Y cells against 6-hydroxydopamine-induced neurotoxicity by upregulating autophagy.
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Humans; Neuroblastoma; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Pyruvic Acid; Reactive Oxygen Species | 2023 |
Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus.
Topics: Animals; Avoidance Learning; Behavior, Animal; Cell Count; Cell Death; Cyclooxygenase 2; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Agonists; Hippocampus; Immunohistochemistry; Interleukin-1beta; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Pyruvates; Reaction Time; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha | 2006 |